Can CYP1A2 help with gut health?

CYP1A2 is primarily known for metabolizing caffeine and certain drugs. Direct evidence linking CYP1A2 to gut health is limited. Caffeine and its metabolites can influence gut motility and the microbiome, and since CYP1A2 determines caffeine clearance rate, a slow-metabolizer genotype could theoretically prolong caffeine exposure in the gut. However, most studies focus on caffeine effects rather than CYP1A2 genotypes directly. CYP1A2 is mainly expressed in the liver, not the gut. A DNA test for CYP1A2 variants (e.g., rs762551) can indicate caffeine sensitivity, but claims about gut health are speculative. Established factors like fiber, probiotics, and inflammatory markers are far more relevant. Conclusion: CYP1A2 is not a validated marker for gut health; evidence is mostly mechanistic and indirect.